Devyser Diagnostics AB (publ) (STO: DVYSR)
Sweden
· Delayed Price · Currency is SEK 129.00
-3.50 (-2.64%)
Jan 20, 2025, 5:29 PM CET
Devyser Diagnostics AB Revenue
Devyser Diagnostics AB had revenue of 48.70M SEK in the quarter ending September 30, 2024, with 4.28% growth. This brings the company's revenue in the last twelve months to 198.10M, up 25.30% year-over-year. In the year 2023, Devyser Diagnostics AB had annual revenue of 169.30M with 33.73% growth.
Revenue (ttm)
198.10M
Revenue Growth
+25.30%
P/S Ratio
10.64
Revenue / Employee
1.66M
Employees
118
Market Cap
2.13B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 25.44B |
| Getinge AB | 33.59B |
| Sectra AB | 3.14B |
| Camurus AB | 1.69B |
| Medicover AB | 22.60B |
| Vitrolife AB | 3.56B |
| Bonesupport Holding AB | 814.46M |
| Elekta AB | 17.72B |